Processa Pharmaceuticals CEO Dr. David Young Issues Letter
HANOVER, MD., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical stage company...
David Young Processa Pharmaceuticals Inc Drug Division Chief Executive Officer Fellow Shareholder Regulatory Science
Source: globenewswire.com